Long-term Outcomes After ICU Treatment for Sepsis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational registry enrolling adults with sepsis admitted to ICUs. Data on clinical features, severity, and outcomes will be collected during hospitalization and at 3, 6, and 12 months post-discharge to describe short- and long-term health and mortality. The study is conducted in up to 30 ICUs in Brazil and uses standard care with no experimental interventions. It aims to identify factors associated with disease severity, hospital outcomes, and longer-term recovery. Enrollment requires informed consent and will target at least 760 participants aged 18 or older.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of sepsis or septic shock during ICU hospitalization, according to the Sepsis-3 definition.
* Age ≥18 years.
* Written informed consent obtained from the participant or a legally authorized representative.

Exclusion Criteria:

* Limited prognosis with a life expectancy of less than 3 months due to conditions not related to sepsis.
* Refusal to participate in the study

Where it's running

• Hospital São Vicente de Paulo
  Passo Fundo, Rio Grande do Sul, Brazil Recruiting

Study contacts

• Study coordinator: Luciano C P Azevedo
• Email: luciano.azevedo@einsten.br
• Phone: 55+ 112151-1233

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care

  This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07922213

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• Neutrophil EMR3 as a biomarker for sepsis in ICU patients

  Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07896018

• Thymalfasin added to standard care for adults with sepsis and immune dysfunction

  This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07866118

• Multicenter group study of sepsis and ARDS in China

  This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.

  Recruiting at 24 sites Shanghai Zhongshan Hospital · Xiamen, Fujian and 23 other locations · NCT07863908

• Non-invasive hemodynamic guidance for sepsis care on medical wards

  This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.

  Recruiting at 2 sites Regione del Veneto - AULSS n. 7 Pedemontana · Pisa, Pisa and 1 other locations · NCT07863323

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.